Jennifer L. Hsiao, MD

Clinical Professor of Dermatology (Clinician Educator)

Is this your profile? Click to edit

Request an Appointment

Publications

Author Correction: Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. Nat Med. 2026 Oct 21.. View in PubMed
Impact of Biologic Therapy on Emergency Department Utilization in Pediatric Hidradenitis Suppurativa Patients. Pediatr Dermatol. 2026 Oct 08.. View in PubMed
Allergens and Marketing Claims of Popular Over-the-Counter Deodorants. Dermatitis. 2026 Oct 01; 17103568261492616.. View in PubMed
Management Considerations for Patients with Hidradenitis Suppurativa and Lupus Spectrum Disease: A Narrative Review. Dermatol Ther (Heidelb). 2026 Sep 29.. View in PubMed
Recent advances in hidradenitis suppurativa therapeutics: a focus on existing and future medical therapeutics. Expert Opin Emerg Drugs. 2026 Sep 09; 1.. View in PubMed
Advancing Our Understanding of Hidradenitis Suppurativa: A Comprehensive Guide for Clinicians Designed to Improve Therapeutic Outcomes for Patients-Part 2. J Clin Aesthet Dermatol. 2026 Sep; 19(9):25-35.. View in PubMed
Advancing Our Understanding of Hidradenitis Suppurativa: A Comprehensive Guide for Clinicians Designed to Improve Therapeutic Outcomes for Patients-Part 1. J Clin Aesthet Dermatol. 2026 Aug; 19(8):20-29.. View in PubMed
Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. Nat Med. 2026 Aug; 32(8):3071-3081.. View in PubMed
American Academy of Dermatology 2026 Annual Meeting: Updates in Hidradenitis Suppurativa Medical Management. Dermatol Ther (Heidelb). 2026 Sep; 16(9):4241-4248.. View in PubMed
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis. Am J Clin Dermatol. 2026 Sep; 27(5):959-975.. View in PubMed

Jennifer L. Hsiao, MD

Publications

Similar People